Markets › United States › NAS › BFRI

Biofrontera Inc

NAS:BFRIHealthcarenasdaq_composite

$0.8040−0.21%At closeAt close · Wed 21 Oct · ≈ AED 2.95 · Market cap $11.94M · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	51.9%	47.1%	47.0%	48.8%	50.1%	78.7%	—	—
Operating margin	−51.0%	−104.6%	−64.8%	−66.6%	−46.1%	−21.9%	−21.9%	+0.0 pts
Net margin	−58.3%	−156.5%	−2.2%	−59.1%	−47.6%	−25.3%	−25.3%	+0.0 pts
EBITDA margin	−39.6%	−152.5%	3.3%	−54.2%	−38.7%	−22.0%	—	—
Return on equity	−188.5%	−332.6%	−2.7%	−420.0%	−400.6%	−100.5%	−100.5%	+0.0 pts
Return on assets	−45.5%	−70.9%	−1.3%	−72.1%	−80.4%	−36.9%	−36.9%	+0.0 pts
Return on capital employed	−48.7%	−64.0%	−62.0%	−230.4%	−170.7%	−54.9%	—	—
Debt / equity	0.0×	0.0×	0.1×	1.1×	1.1×	0.6×	0.6×	+0.0%
Debt / assets	0.0%	0.0%	2.6%	19.3%	22.3%	21.6%	—	—
Interest coverage	−3.3×	−70.0×	−50.2×	−37.8×	−8.2×	−20.2×	—	—
Current ratio	4.4×	3.4×	2.1×	1.3×	1.7×	1.5×	1.5×	+0.0%
Quick ratio	2.8×	3.0×	1.7×	0.7×	1.2×	1.4×	—	—
Cash ratio	1.8×	1.8×	0.8×	0.1×	0.5×	0.5×	0.5×	+0.0%
Asset turnover	0.8×	0.5×	0.6×	1.2×	1.7×	1.5×	—	—
Inventory turnover	1.3×	2.9×	2.1×	1.6×	2.8×	6.2×	—	—
Receivables turnover	5.7×	6.4×	3.9×	6.6×	7.0×	5.7×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—